Vacancy caducado!
Ustekinumab (Stelara®), Vedolizumab (Entyvio®), Infliximab-dyyb (Inflectra)
Crohn's Disease, Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, Rheumatoid Arthritis or Ankylosing Spondylitis
As part of a clinical research study, PrecisionMed is seeking volunteers with physician diagnosis of one of the above listed diseases who are 18 years or older and who are taking or have taken one of the following medications:
Ustekinumab (Stelara®)
Vedolizumab (Entyvio®)
Infliximab-dyyb (Inflectra)
Procedures for this single one hour study visit will involve providing health information and blood sampling.
Participants will receive $350 compensation at the time of the visit.
Vacancy caducado!